华森制药：成都地建3.00%减持完成

Core Viewpoint - The company announced a significant reduction in shareholding by its controlling shareholder, Chengdu Local Construction Machinery Engineering Co., Ltd., and by senior management personnel, indicating a strategic shift in ownership structure [1] Shareholding Reduction - The controlling shareholder reduced its stake by a total of 12.52 million shares, representing 3.00% of the total share capital, through two methods: centralized bidding and block trading [1] - From June 6 to July 29, 2025, 4.1759 million shares were sold via centralized bidding at a price range of 17.4 to 19.29 CNY per share [1] - During the same period, 8.3519 million shares were sold through block trading at a price range of 14.51 to 16.27 CNY per share [1] Management Shareholding - Senior management personnel, specifically Peng Xiaoyan, also participated in share reduction by selling a total of 4,300 shares, which is 0.0010% of the total share capital [1] - The sales occurred on June 12 and June 19, 2025, at prices of 17.98 CNY and 16.33 CNY per share, respectively [1] Completion of Reduction Plan - The share reduction plan has been fully implemented, indicating a completed transition in the ownership structure [1]